Skip to content
The GLP-1 Verdict
Menu
Ranked #101 · Grade C

Amble review

Telehealth weight loss provider offering compounded semaglutide and tiered tirzepatide programs.

Visit Amble Assume we may earn a commission, at no cost to you. It never changes The Verdict Score, nor a word of this review.
Semaglutide
From $179/mo (starting dose, compounded)
Tirzepatide
From $289/mo (starting dose, compounded)
Coverage
All 50 states
Brand-name
Compounded only

The scorecard

Amble scored on our six published factors. See the methodology.

Real-world results75/100
Price honesty64/100
Prescriber access90/100
Formulary choice82/100
Cancellation fairness56/100
Member support70/100

What we like

  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

The caveats

  • Limited public information on program details

The verdict

Best for: Shoppers who want mainstream telehealth GLP-1 access. Telehealth weight loss provider offering compounded semaglutide and tiered tirzepatide programs.

Ranked #101 of 539 providers we have reviewed — for comparison, read what CoreAge Rx scores, and why, our #1 pick. In the ranking it sits between AmberHealth at #100, 73/100 above and Corsica Health at #102, 73/100 below, with the GOAL.MD ruling the next one down.

If that ruling leaves you undecided, the 7 programs we rank against Amble are graded on the same six factors and listed in score order.This ruling sits inside a bigger one: the complete ranking puts this ruling in context against every program we track. We have also ruled on it directly: CoreAge Rx vs Amble goes to CoreAge Rx, 94/100 to 73/100.

Compare with other providers

The closest rulings to Amble by Verdict Score — the realistic shortlist if you are weighing this one up.

Browse all 539 rulings, ranked →

Pricing, states and verification reflect Amble's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on Amble's site. Not medical advice; see our disclosure.

← Back to all rankings